Mirum Pharmaceuticals, Inc.MIRMNASDAQ

Revenue (LTM)

$521M

+54.7% YoY

Net Income (LTM)

$-23M

+73.4% YoY

Free Cash Flow

$55M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF$0.1B

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	19	77↑302.7%	186↑141.8%	337↑80.8%	521↑54.7%
Gross Profit	17	65↑275.3%	139↑115.4%	255↑83.2%	421↑64.8%
Operating Income	-173	-131↑24.3%	-109↑16.8%	-88↑19.7%	-22↑74.7%
Net Income	-84	-136↓61.5%	-163↓20.5%	-88↑46.2%	-23↑73.4%
EBITDA	-65	-123↓87.9%	-136↓11.1%	-49↑64.1%	17↑135.1%
EPS Diluted	-2.77	-4.02↓45.1%	-4.00↑0.5%	-1.85↑53.8%	-0.47↑74.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	31	28↓10.6%	286↑922.5%	223↓22.3%	297↑33.3%
Total Current Assets	167	190↑14.2%	388↑103.7%	393↑1.4%	550↑39.9%
Total Assets	295	353↑19.8%	647↑83.2%	671↑3.7%	843↑25.7%
Total Current Liabilities	43	65↑52.0%	87↑34.5%	127↑45.4%	206↑62.6%
Total Liabilities	174	211↑20.9%	398↑88.7%	445↑11.9%	528↑18.6%
Total Equity	120	142↑18.2%	249↑75.1%	226↓9.3%	315↑39.5%
Total Debt	3	2↓16.3%	308↑13983.3%	318↑3.1%	319↑0.5%
Net Debt	-29	-26↑10.1%	22↑184.5%	95↑336.7%	23↓76.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-133	-120↑9.5%	-71↑40.9%	10↑114.6%	56↑440.7%
Capital Expenditure	-19	-0↑98.5%	-20↓7133.5%	-1↑95.1%	-1↑3.9%
Free Cash Flow	-152	-120↑20.7%	-91↑24.4%	9↑110.2%	55↑488.0%
Stock-Based Comp	23	27↑17.0%	35↑29.7%	48↑38.3%	71↑47.4%
Net Change in Cash	-11	-3↑68.9%	158↑4844.5%	-63↓140.0%	75↑218.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance